Jiangsu Lanfeng Bio-chemicalLtd Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Jiangsu Lanfeng Bio-chemicalLtd şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

-1.3%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-1.3%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	CN¥0.040
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry

Nov 09

Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price

Sep 25

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Jun 07

The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%

Feb 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 002513 şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: 002513 şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Jiangsu Lanfeng Bio-chemicalLtd Piyasaya Karşı Temettü Getirisi

002513 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (002513)	0%
Pazarın Alt %25'i (CN)	0.5%
Pazarın En İyi %25'i (CN)	2.1%
Sektör Ortalaması (Chemicals)	1.7%
Analist tahmini (002513) (3 yıla kadar)	n/a

Önemli Temettü: 002513 şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, 002513 şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: 002513 CN piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 002513 herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Jiangsu Lanfeng Bio-chemicalLtd Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry

New minor risk - Share price stability

Third quarter 2024 earnings released: CN¥0.12 loss per share (vs CN¥0.11 loss in 3Q 2023)

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price

Second quarter 2024 earnings released: CN¥0.32 loss per share (vs CN¥0.20 loss in 2Q 2023)

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report First Half, 2024 Results on Aug 06, 2024

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

First quarter 2024 earnings released: CN¥0.082 loss per share (vs CN¥0.043 loss in 1Q 2023)

Jiangsu Lanfeng Bio-chemical Co.,Ltd, Annual General Meeting, May 23, 2024

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%

New minor risk - Share price stability

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.006 loss in 3Q 2022)

New major risk - Financial position

Second quarter 2023 earnings released: CN¥0.20 loss per share (vs CN¥0.004 profit in 2Q 2022)

Jiangsu Lanfeng Bio-Chemical Co.,Ltd Approves Management Elections

New minor risk - Share price stability

Zheng Xu acquired a 18.04% stake in Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) from Jiangsu Suhua Group Co., Ltd. and Suzhou Gelin Investment Management Co., Ltd. for approximately CNY 300 million.

Zheng Xu acquired a 18.04% stake in Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) from Jiangsu Suhua Group Co., Ltd. and Suzhou Gelin Investment Management Co., Ltd. for approximately CNY 300 million.

Full year 2022 earnings released: CN¥0.88 loss per share (vs CN¥1.44 loss in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.076 loss in 3Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.003 (vs CN¥0.004 in 1Q 2021)

High number of new directors

Jiangsu Lanfeng Bio-chemical Co.,Ltd, Annual General Meeting, May 10, 2022

Full year 2021 earnings released: CN¥1.44 loss per share (vs CN¥0.04 profit in FY 2020)

Third quarter 2021 earnings released: CN¥0.076 loss per share (vs CN¥0.06 profit in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.04 loss per share (vs CN¥0.017 profit in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.004 (vs CN¥0.05 loss in 1Q 2020)

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day low: CN¥3.50

New 90-day low: CN¥3.53

New 90-day low: CN¥3.90

New 90-day high: CN¥4.37

Third quarter earnings released

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Q3, 2020 Results on Oct 23, 2020

New 90-day high: CN¥4.30

Taicang Yunzaifei Material Trading Co., Ltd. signed an agreement to acquire Taicang Lanfeng Chemical Co., Ltd. from Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) for CNY 10.8 million.

New 90-day low - CN¥3.86

First half earnings released

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report First Half, 2020 Results on Aug 25, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin